Background: Atopic dermatitis (AD) associated with respiratory atopy may represent a form of systemic contact dermatitis (SCD), whereby AD flares after ingestion or inhalation of allergens.
C hronic skin inflammation predisposes to sensitization to weak irritants, including food allergens, and predisposes to T-helper 2 (T H 2)-skewed immune responses.
1,2 Both T-helper 1 (T H 1) and T H 2 immune responses can occur to some allergens, such as nickel and fragrance, and notably, T H 2 responses may be more durable than T H 1 responses in the setting of cutaneous sensitization with chronic inflammation. [3] [4] [5] [6] [7] Thus, cutaneous sensitization in the context of inflamed skin likely plays a key role in the development of systemic allergen sensitization in the atopic march. [8] [9] [10] [11] [12] [13] [14] [15] Chronic barrier inflammation occurs in childhood-onset dermatitis, or atopic dermatitis (AD), and in wet work. 14, 15 Allergic contact dermatitis to foods is reported exclusively in patients in these 2 settings, that is, with AD or wet work and food handling. Moreover, cutaneous sensitization to allergens that can be ingested or inhaled, including peanut, grass pollen, and Compositae, is increasingly recognized in AD. [16] [17] [18] [19] [20] Systemic contact dermatitis (SCD) occurs after cutaneous sensitization and the subsequent generation of skin-homing cutaneous lymphocyte-associated antigen (CLA) + T cells specific for ingested or inhaled allergens. [21] [22] [23] [24] Thus, AD associated with respiratory atopy may represent a form of SCD, whereby flaring of AD occurs when cutaneously sensitized patients are reexposed to allergens through the gastrointestinal or upper respiratory tracts. Our objective was to compare the prevalence of positive patch tests to allergens known to cause SCD among AD patients with and without respiratory atopy patch tested for suspicion of allergic contact dermatitis. This approach was driven by a list of allergens known to cause SCD, rather than starting with patient characteristics of atopy compared with nonatopic patients patch tested to a standard screening series as previously reported.
MATERIALS AND METHODS

Allergen Selection
This study was approved by the institutional review board. Allergens associated with SCD were identified a priori and agreed upon by 2 independent investigators (J.F.S. and S.T.N.). We began with a comprehensive set of allergens known to be associated with SCD identified from Fisher's Contact Dermatitis (6th edition) and a PubMed literature search using the key word "systemic contact dermatitis." 25 We did not consider allergens reported to cause SCD through a primarily non-type IV hypersensitivity mechanism of action, including anaphylaxis (eg, formaldehyde, paraformaldehyde) and erythema multiforme (eg, disperse blue 124, epoxy resin). 25 Allergens reported to cause SCD through cross-reactions with other ingested or inhaled compounds (eg, aminoglycosides, sulfonamides, phenothiazines) were also not considered. 25 Finally, various allergens reported to cause SCD, including food and aeroallegen proteins, carmine, and sorbic acid, among others, were excluded from the final analysis because these allergens were patch tested in less than 50% of patients. In total, 23 allergens patch tested in more than 50% of patients were included in the final analysis. These allergens were broadly categorized as plant derivatives (n = 9), metals (n = 4), steroids (n = 6), and miscellaneous (n = 4). Atopic dermatitis was defined as a physician-assessed history of childhood flexural dermatitis. Patients with AD were stratified by the presence of respiratory atopy, defined as a self-reported history of asthma and/or allergic rhinitis. Patients with AD were further stratified by age (<18 vs ≥18 years) and occupation (wet vs dry work). Occupations were classified as wet or dry work by a single investigator (S.T.N.) based on job duties elicited at the initial clinic visit, as previously described. 15 
Study Cohort
Statistical Analysis
Basic demographic characteristics, including age, sex, and race, were extracted for patients with AD. The total number of patch tests and the number of positive and negative patch test results for the 23 allergens known to cause SCD were determined for AD patients with and without respiratory atopy. Positive patch tests were compared between the following: (1) AD patients with and without respiratory atopy; (2) AD patients with and without respiratory atopy stratified by age (<18 vs ≥18 years); and (3) AD patients with and without respiratory atopy stratified by occupation (wet vs dry work). Fisher exact test was used to compare the relative frequencies of positive reactions. After constructing odds ratios (ORs) from the test data comparing each set of groups where there were no zero counts of positive patch tests, the 95% confidence intervals (CIs) for each comparison were constructed by the method of Cornfeld. 27 Haldane method was used to construct OR and 95% CI for comparisons involving zero positive patch test results. 28 All statistical analyses were performed using R statistical software, version 3.4.1. P values ≤ 0.05 were considered statistically significant.
RESULTS
A total of 457 patients with AD (18.9%) and 1959 patients without AD (81.1%) were patch tested for suspicion of allergic contact dermatitis between 2003 and 2017. Of these, 278 AD patients with respiratory atopy (60.8%) and 179 AD patients without respiratory atopy (39.2%) were identified (Table 1) . More adult patients with AD had respiratory atopy (P = 0.02), but otherwise, the groups were similar with regard to sex, race, and occupation type. Overall, the percentage of positive patch tests to these allergens was 3.7% and 2.9% for AD patients with and without respiratory atopy, respectively (OR, 1.28; 95% CI, 0.99-1.66; P = 0.07). Of note, there was no difference in patch test results among non-AD patients with and without respiratory atopy (OR, 0.93; 95% CI, 0.82-1.05; P = 0.24). Atopic dermatitis patients with respiratory atopy also had a significantly higher percentage of positive patch tests to metals compared with AD patients without respiratory atopy (11.4% vs 7.9%, P = 0.04). There was no difference in the percentage of positive patch tests to metals in AD patients with respiratory atopy stratified by the presence of dyshidrotic eczema (OR, 1.20; 95% CI, 0.82-1.74; P = 0.37).
Patients with AD younger than 18 years with respiratory atopy were significantly more likely than those without respiratory atopy to have positive patch tests to the combined 23 allergens (OR, 2.33; 95% CI, 1.13-4.78; P = 0.02) ( Table 3 ). There was no difference in patch test results among AD patients older than 18 years with and without respiratory atopy (OR, 1.15; 95% CI, 0.87-1.52; P = 0.34). Atopic dermatitis patients with respiratory atopy engaging in wet work, but not dry work, occupations were also more likely to have positive patch tests to the combined 23 allergens compared with AD patients without respiratory atopy (OR, 1.47; 95% CI, 1.05-2.06; P = 0.03) ( Table 3) .
DISCUSSION
Positive patch tests to allergens known to cause SCD are more common in AD patients with respiratory atopy who are younger than 18 years compared with older patients with a history of AD presenting to a dermatitis clinic, and this is also true for patients doing wet work. These data support the previous studies documenting increased rates of positive patch tests to certain allergens in patients with a personal or family history of atopy of any type, as well as increased sensitization to aeroallergens in patients with AD. 16, [29] [30] [31] This study suggests that AD associated with respiratory atopy may signal an immune system capable of developing SCD, in which flaring of AD occurs after systemic exposure to allergens. A T-cell response is detected by patch testing. Some patients with a T-cell response may exhibit SCD after ingestion or inhalation of an allergen if the T cells are CLA + and home to areas of skin that have previously been in contact with the allergen. 24 This work included only commercially available allergens commonly tested on a standard screening series in most of our cohort. The logical extension of our conclusions is that SCD to foods and aeroallergens may trigger AD in patients with respiratory atopy (ie, extrinsic AD) who have antigen-specific CLA + cells. The T H 2-skewed immune responses are characteristic of patients with AD and respiratory atopy. 32 In contrast, the T H 1-skewed immune responses seen in AD patients without respiratory atopy predispose these patients to have less propensity for developing systemic allergen sensitization. 32, 33 Food and pollen allergens are low-potency allergens, consistent with previous work showing that barrier disruption, either from AD or from wet work, is likely necessary to create the innate immune signals required for cutaneous sensitization to less potent allergens. 15, 34 In our study, AD patients with respiratory atopy and those patients engaging in wet work were consistently found to have higher rates of positive patch tests to propylene glycol, a weak sensitizer.
This study is limited by its retrospective design, which cannot determine causation and lends itself to misclassification and recall biases. It is also possible that patients with nonatopic etiologies of dermatitis, asthma, and/or rhinitis were incorrectly classified as having AD and respiratory atopy. Moreover, we only considered patch testing as an assay for cutaneous delayed-type hypersensitivity. Therefore, no conclusions can be drawn regarding the prevalence of systemic sensitization, SCD, or allergic contact dermatitis in our cohort. In addition, the occupation classifications used in this study only represent current rather than previous jobs and may not fully reflect all wet exposures. Finally, it is possible that some younger patients in the process of progressing through the atopic march had not yet developed respiratory symptoms at the time of patch testing and may have been misclassified as not having respiratory atopy.
In conclusion, patients with AD, respiratory atopy, and environmental barrier dysfunction in the form of wet work are characterized by increased positive patch tests to ingested or inhaled allergens known to cause SCD. Patch testing may be of important diagnostic and therapeutic value in AD patients with respiratory atopy, particularly when focusing on specialized allergen series that include weak allergens, food additives, and aeroallergens. The identification of systemic triggers of AD with patch testing, and subsequent systemic and topical avoidance of relevant food additives and aeroallergens, could decrease the frequency of AD flares. Ultimately, patch testing could act as a "steroid-sparing agent," reducing the use of corticosteroids and other immunosuppressive medications in the management of patients with AD.
